Eli Lilly highlighted 2025 as the rollout year for obesity drugs, with Mounjaro at the forefront of its weight-loss portfolio ...

Beacon Securities analyst Russell Stanley reiterated a “Buy” rating and maintained his $17.00 target price on FTG ...

WuXi AppTec highlighted the strength of its integrated CRDMO model and growing exposure to late-stage and commercial assets ...

Rocket Lab shares surge 6% to record high on $816M defense contract. Analyst calls company top SpaceX alternative ahead of ...

Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

Bernstein names aerospace manufacturer top 2026 pick, raises target to $298 on production growth and cash flow projections of ...

Additionally, President Donald Trump has called for growing a "vibrant commercial space economy" and plans to ramp up defense ...

Old Republic International (ORI) remains fundamentally strong but is overvalued, warranting a 'Hold' rating with a $29/share ...

Kraken Robotics is overvalued amidst competitive and customer risks. Click here to read what investors need to know.

Morgans' Scott Power is positive of renewed momentum in the healthcare sector, which has risen 0.9% in the week ending ...

Councils in southwest Queensland may soon enter the insurance market, in an Australian-first for local government, offering ...